ArticleThe oncologist2020

A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma.

Andrew W Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.